Mammoth Biosciences develops CRISPR-based technologies for molecular diagnostics and programmable gene editing. The company leverages proprietary CRISPR systems and engineered Cas enzymes to create rapid, high-sensitivity diagnostic assays and platform capabilities for therapeutic discovery and precision genome manipulation.
Leadership & Board
Current Number of Employees164
Current LinkedIn Followers57,996
Latest Estimated Valuation
Estimated Valuation―
Estimated Valuation―
Total Amount Raised$95M
Total Amount Raised$95M
Total Funding Rounds1
Total Funding Rounds1
Latest Funding Amount$95M
Latest Funding Amount$95M
Latest Funding RoundInvestment
Latest Funding RoundInvestment
Post-Money Valuation―
Post-Money Valuation―
Employee Trend
Mammoth Biosciences had 164 employees as of May 25, 2026. The number of employees decreased by 1 (0.61%) week-over-week.
164Latest Employee Count
1(-0.61%)Week-Over-Week Change
Employee Trend serves as a data-driven indicator of company growth and expansion. The measurement reflects how a company’s workforce size changes over time.
Social Trend
Mammoth Biosciences had 57,996 followers as of May 25, 2026. The number of followers increased by 98 (0.17%) week-over-week.
57,996Latest Followers Count
98(0.17%)Week-Over-Week Change
LinkedIn Follower Trend serves as a data-driven indicator of market interest and company visibility. The measurement reflects how a company’s LinkedIn follower count changes over time.
Funding Round
May 25, 2024
Investment
$95.00M
―
Investors
Investment
